Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia.
Oksana Dmitryevna GurievaMarina Ivanovna SavelyevaTimur Tejmurazovich ValievZhannet Alimovna SozaevaSvetlana Nikolaevna KondratenkoMikhail Vitalyevich IlyinPublished in: Drug metabolism and personalized therapy (2023)
Complementing the existing criteria for pediatric ALL risk groups with pharmacogenetic indicators will allow further individualization of therapy.